STOCK TITAN

Durect Corp (DRRX) Financials

DRRX
FY2024 annual
Revenue $2.0M -21.6% YoY
Net Income -$8.3M +69.9% YoY
EPS (Diluted) -$0.27 +77.5% YoY
Free Cash Flow -$19.1M +44.6% YoY
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2025, ended Jun 30, 2025 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2025, filed Aug 13, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DRRX SEC filings page.

Durect Corp (DRRX) reported $2.0M in revenue for fiscal year 2024, down 21.6% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI DRRX FY2024

A development-stage cost base overwhelms limited revenue, leaving operating losses to drive cash use despite minimal capital spending.

FY2024 operating cash flow and free cash flow were identical at -$19.1M because no capital expenditures were reported, so the cash burden came from the operating structure rather than reinvesting in facilities or equipment. The cash conversion gap was also wide: the net loss was -$8.3M, meaning cash outflow exceeded accounting losses by more than two times.

The cost structure is still development-led: R&D and SG&A together exceeded $20M against FY2024 revenue of $2.0M, so the business cannot yet absorb its operating cost base through sales. The operating loss narrowed from -$39.7M in FY2023 to -$18.9M in FY2024 while revenue fell, pointing to expense reduction rather than scale as the main improvement.

Assets more than halved from $45.2M in FY2023 to $18.3M in FY2024 while liabilities also contracted, indicating a shrinking balance sheet rather than growth financed by accumulating assets. The current ratio improved from 1.3x to 1.7x, while reported liquidity equaled 7.4 months of annual outflow; short-term coverage improved even as operating cash use remained the central funding pressure.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 45 / 100
Financial Health Score 45/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2024. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Durect Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
24

Durect Corp held $11.8M in cash, cash equivalents and investments at the end of fiscal year 2024, and its operations used $19.1M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Durect Corp scores 24/100 among other emerging companies.

Dilution
44

Durect Corp had 31M shares outstanding at the end of fiscal year 2024, against 31M in fiscal year 2023. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Durect Corp scores 44/100 among other emerging companies.

R&D Intensity
77

Durect Corp spent $10.4M on research and development in fiscal year 2024, which was 49.6% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Durect Corp scores 77/100 among other emerging companies.

Revenue Progress
1

Durect Corp reported revenue of $2.0M in fiscal year 2024, against $2.6M in fiscal year 2023. Revenue Progress ranks emerging companies on the three-year path of that line, and Durect Corp scores 1/100 among other emerging companies.

Burn Trend
59

Durect Corp's operations used $19.1M of cash in fiscal year 2024, against $34.4M used in fiscal year 2023. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Durect Corp scores 59/100 among other emerging companies.

Balance Sheet
64

Durect Corp's cash, cash equivalents and investments came to $11.8M at the end of fiscal year 2024, against $9.2M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Durect Corp scores 64/100 among other emerging companies.

Altman Z-Score Distress
-44.65

Durect Corp scores -44.65, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($59.3M) relative to total liabilities ($9.2M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
4/8

Durect Corp passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality No Cash Backing
N/A

Durect Corp reported a net loss of $8.3M while operations used $19.1M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$447K
YoY-30.8%
QoQ+39.3%

Durect Corp generated $447K in revenue in Q2 2025. This represents a decrease of 30.8% from the same quarter a year earlier. Against the prior quarter it is up 39.3%.

EBITDA
-$2.8M
YoY+33.7%
QoQ+31.6%

Durect Corp's EBITDA was -$2.8M in Q2 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 33.7% from the same quarter a year earlier. Against the prior quarter it is up 31.6%.

Net Income
-$2.3M
YoY+38.8%
QoQ+46.5%

Durect Corp reported -$2.3M in net income in Q2 2025. This represents an increase of 38.8% from the same quarter a year earlier. Against the prior quarter it is up 46.5%.

EPS (Diluted)
-$0.07
YoY+41.7%
QoQ+46.2%

Durect Corp earned -$0.07 per diluted share (EPS) in Q2 2025. This represents an increase of 41.7% from the same quarter a year earlier. Against the prior quarter it is up 46.2%.

Cash & Balance Sheet

Free Cash Flow
-$1.8M
QoQ+50.4%

Durect Corp recorded an outflow of $1.8M in free cash flow in Q2 2025, representing a cash shortfall after capex. Against the prior quarter it is up 50.4%.

Cash & Debt
$6.5M
YoY-58.4%
QoQ-18.3%
5Y CAGR-18.8%
10Y CAGR+0.8%

Durect Corp held $6.5M in cash as of Q2 2025; long-term debt is not reported for that period.

Shares Outstanding
31M
YoY0.0%
QoQ0.0%
5Y CAGR-31.1%
10Y CAGR-12.7%

Durect Corp had 31M shares outstanding in Q2 2025. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q2 2025.

Margins & Returns

Gross Margin
98.4%
YoY+2.6pp

Durect Corp's gross margin was 98.4% in Q2 2025, indicating the percentage of revenue retained after direct costs. This is up 2.6 percentage points from the same quarter a year earlier.

Return on Equity
-65.0%
YoY+8.4pp
QoQ+14.1pp

Durect Corp's ROE was -65.0% in Q2 2025, measuring profit generated per dollar of shareholder equity. This is up 8.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 14.1 percentage points.

Operating Margin

Not shown for Q2 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q2 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending
$1.2M
YoY-47.7%
QoQ-37.5%

Durect Corp invested $1.2M in research and development in Q2 2025. This represents a decrease of 47.7% from the same quarter a year earlier. Against the prior quarter it is down 37.5%.

Capital Expenditures
$0
QoQ-100.0%

Durect Corp reported no capital expenditure in Q2 2025. Against the prior quarter it is down 100.0%.

Share Buybacks

Not reported for Q2 2025.

DRRX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DRRX quarterly income statement
MetricQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$447K-30.8%$321K-35.3%N/A$1.9M+10.5%$646K-69.0%$496K-75.9%N/A$1.7M-85.4%
Cost of Revenue$7K-74.1%N/AN/A$513K+64.4%$27K-92.5%$289K-25.5%N/A$312K-9.6%
Gross Profit$440K-28.9%N/AN/A$1.4M-1.3%$619K-64.1%$207K-87.6%N/A$1.4M-87.7%
R&D Expenses$1.2M-47.7%$1.9M-54.3%N/A$2.2M-69.9%$2.2M-71.7%$4.1M-52.1%N/A$7.2M-27.1%
SG&A Expenses$2.1M-19.4%$2.6M-3.9%N/A$3.2M-15.1%$2.6M-33.0%$2.7M-34.5%N/A$3.8M-2.4%
Operating Income-$2.8M+33.2%-$4.1M+34.3%N/A-$4.0M+58.5%-$4.2M+58.3%-$6.3M+42.8%N/A-$9.6M-348.3%
EBITDA-$2.8M+33.7%-$4.1M+34.9%N/A-$3.9M+58.4%-$4.2M+58.1%-$6.3M+43.0%N/A-$9.5M-353.2%
Net Income-$2.3M+38.8%-$4.2M+44.6%N/A-$4.3M-42.1%-$3.7M+66.9%-$7.6M+36.2%N/A-$3.0M-22.0%
EPS (Basic)-$0.07+41.7%-$0.13+48.0%$0.24+2500.0%-$0.14-27.3%-$0.12+73.9%-$0.25+50.0%-$0.01+99.3%-$0.110.0%
EPS (Diluted)-$0.07+41.7%-$0.13+48.0%$0.24+284.6%-$0.140.0%-$0.12+73.9%-$0.25+51.9%-$0.13+91.0%-$0.14-27.3%
Diluted Shares (Avg)31M+0.4%31M+1.3%N/A31M+12.8%31M+26.6%31M+28.0%N/A28M+20.8%

Not reported in any period shown, so not listed: Interest Expense, Income Tax.

DRRX Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DRRX quarterly balance sheet
MetricQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Total Assets$12.5M-58.2%$14.4M-60.4%$18.3M-59.4%$24.1M-56.0%$29.9M-38.6%$36.2M-37.9%$45.2M-24.8%$54.7M-20.1%
Current Assets$7.8M-61.0%$9.4M-63.9%$13.2M-62.0%$14.4M-67.1%$19.9M-50.5%$26.1M-48.4%$34.7M-32.5%$43.8M-26.2%
Cash & Equivalents$6.5M-58.4%$8.0M-58.6%$11.0M-61.2%$9.1M-76.7%$15.6M-50.7%$19.3M-51.0%$28.4M-34.7%$39.0M-22.6%
Short-Term Investments$0$297K-86.4%$792K-38.1%$1.3M$0-100.0%$2.2M-55.6%$1.3M$0-100.0%
Inventory$291K-88.2%$85K-96.5%$106K-19.7%$2.4M-5.8%$2.5M+9.4%$2.4M+8.5%$132K-93.8%$2.5M+11.1%
Accounts Receivable$511K-49.5%$330K-67.6%$453K-26.7%$1.0M+15.1%$1.0M-22.4%$1.0M-27.2%$618K-81.9%$883K-72.7%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$2.7M-55.8%$2.7M-55.8%$2.7M-55.8%$6.2M0.0%$6.2M0.0%$6.2M0.0%$6.2M0.0%$6.2M0.0%
Total Liabilities$9.0M-63.7%$9.0M-67.7%$9.2M-69.7%$22.8M-43.3%$24.8M-42.5%$27.9M-35.1%$30.4M-13.4%$40.3M+19.9%
Current Liabilities$7.9M-64.0%$7.7M-69.0%$7.7M-71.5%$20.2M-45.0%$21.9M-47.1%$24.7M-41.2%$27.0M-20.6%$36.8M+175.2%
Non-Current Liabilities$1.1M-61.7%$1.3M-58.0%$1.5M-55.6%$2.6M-26.0%$2.9M+67.3%$3.2M+245.5%$3.4M+205.6%$3.6M-82.4%
Long-Term DebtN/AN/AN/A$10.5M-44.0%$12.5M-39.5%$14.6M-31.4%$16.7M-21.3%$18.7M+4.3%
Total Equity$3.5M-30.9%$5.4M-35.5%$9.1M-38.2%$1.2M-91.6%$5.0M-8.4%$8.3M-45.9%$14.8M-40.8%$14.4M-58.7%
Retained Earnings-$603.8M-0.6%-$601.6M-0.8%-$597.3M-1.4%-$604.6M-2.9%-$600.3M-2.7%-$596.6M-4.1%-$589.0M-4.9%-$587.6M-6.7%

DRRX Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DRRX quarterly cash flow statement
MetricQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Operating Cash Flow-$1.8M+52.0%-$3.5M+47.6%-$5.5M+33.7%-$3.1M+58.1%-$3.7M+60.8%-$6.8M+27.0%-$8.3M+1.0%-$7.5M-235.7%
Depreciation & Amortization$20K+1100.0%$69K+35.3%$12K+109.8%$23K-69.7%-$2K-105.9%$51K+15.9%-$123K-1330.0%$76K+90.0%
Stock-Based Compensation$397K-6.4%$452K-11.2%N/A$458K-30.7%$424K-35.7%$509K-15.4%N/A$661K+14.4%
Capital Expenditures$0$7KN/AN/AN/AN/A$0-100.0%$13K-55.2%
Free Cash Flow-$1.8M-$3.6MN/AN/AN/AN/A-$8.3M+1.2%-$7.5M-232.0%
Investing Cash Flow$300K-86.4%$496K+155.9%$18.0M+1841.8%-$1.3M-143.3%$2.2M+19.5%-$887K+82.0%-$1.0M-170.1%$3.0M-46.0%
Financing Cash FlowN/AN/A-$10.6M-762.1%-$2.1M-118.2%-$2.1M-6194.1%-$1.5M-115.0%-$1.2M-5208.3%$11.8M+46928.0%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

DRRX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DRRX quarterly financial ratios
MetricQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Gross Margin98.4%+2.6ppN/AN/A73.4%-8.7pp95.8%+13.1pp41.7%-39.4ppN/A82.1%-15.0pp
Operating Margin-627.1%-1289.4%N/A-205.9%-649.2%-1271.0%N/A-548.0%
Net Margin-506.7%-1318.4%N/A-222.4%-572.8%-1540.9%N/A-172.9%
Return on Equity-65.0%+8.4pp-79.1%+13.0ppN/A-352.1%-331.2pp-73.5%+129.8pp-92.1%-13.9ppN/A-20.9%-13.8pp
Return on Assets-18.1%-5.8pp-29.5%-8.4ppN/A-17.8%-12.3pp-12.4%+10.6pp-21.1%-0.6ppN/A-5.5%-1.9pp
Current Ratio0.98+0.1x1.23+0.2x1.71+0.4x0.71-0.5x0.91-0.1x1.05-0.1x1.28-0.2x1.19-3.3x
Debt-to-Equity2.58+0.1x1.68-0.1x1.01-0.1x8.60+7.3x2.49-1.3x1.76+0.4x1.13+0.3x1.30+0.8x
Asset Turnover0.040.0x0.020.0xN/A0.080.0x0.020.0x0.010.0xN/A0.03-0.1x
FCF Margin-394.0%-1106.2%N/AN/AN/AN/AN/A-429.8%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Durect Corp DRRX FY2024 $2.0M -$8.3M N/A $59.3M 45/100
Rockwell Medical, Inc. (DE) RMTI FY2025 $69.3M -$5.3M -7.7% $31.6M 53/100
Cumberland Pharmaceuticals Inc CPIX FY2025 $44.5M -$2.8M -6.4% $99.5M 44/100
Assertio Holdings, Inc. ASRT FY2025 $118.7M -$30.4M -25.6% $151.9M 37/100

Frequently Asked Questions

What is Durect Corp's annual revenue?

Durect Corp (DRRX) reported $2.0M in total revenue for fiscal year 2024. This represents a -21.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Durect Corp's revenue growing?

Durect Corp (DRRX) revenue declined by 21.6% year-over-year, from $2.6M to $2.0M in fiscal year 2024.

Is Durect Corp profitable?

No, Durect Corp (DRRX) reported a net income of -$8.3M in fiscal year 2024.

Durect Corp (DRRX) reported diluted earnings per share of -$0.27 for fiscal year 2024. This represents a 77.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Durect Corp (DRRX) had EBITDA of -$18.8M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

Durect Corp (DRRX) had a gross margin of 96.2% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

Durect Corp (DRRX) has a return on equity of -91.2% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

Durect Corp (DRRX) recorded an outflow of $19.1M in free cash flow during fiscal year 2024. This represents a 44.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Durect Corp (DRRX) recorded an outflow of $19.1M in operating cash flow during fiscal year 2024, representing cash used by core business activities.

Durect Corp (DRRX) had $18.3M in total assets as of fiscal year 2024, including both current and long-term assets.

Durect Corp (DRRX) reported no capital expenditure during fiscal year 2024.

Durect Corp (DRRX) invested $10.4M in research and development during fiscal year 2024.

Durect Corp (DRRX) had 31M shares outstanding as of fiscal year 2024.

Durect Corp (DRRX) had a current ratio of 1.71 as of fiscal year 2024, which is generally considered healthy.

Durect Corp (DRRX) had a debt-to-equity ratio of 1.01 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

Durect Corp (DRRX) had a return on assets of -45.4% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

At the end of fiscal year 2024, Durect Corp (DRRX) held $11.8M in cash, cash equivalents and investments, and reported an operating cash outflow of $19.1M over that year. Dividing the one by the other, the reported balance equals about 7 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Durect Corp (DRRX) has an Altman Z-Score of -44.65, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Durect Corp (DRRX) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Durect Corp (DRRX) reported a net loss of $8.3M while operations used $19.1M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Durect Corp (DRRX) scores 45 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top